News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Cormorant Asset Management, LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/10/2023 |
SC 13G
| Cormorant Asset Management, LP reports a 5.5% stake in Marinus Pharmaceuticals, Inc. |
| 12/29/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/27/2022 |
SC 13G
| Cormorant Asset Management, LP reports a 5.1% stake in Avidity Biosciences, Inc. |
| 10/31/2022 |
SC 13G
| Cormorant Asset Management, LP reports a 7.8% stake in Cabaletta Bio, Inc. |
| 09/02/2022 |
SC 13G
| Cormorant Asset Management, LP reports a 5.4% stake in Astria Therapeutics, Inc. |
| 08/29/2022 |
SC 13G
| Cormorant Asset Management, LP reports a 5% stake in Arcellx, Inc. |
| 07/07/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/17/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/06/2022 |
SC 13G
| Cormorant Asset Management, LP reports a 5.7% stake in Prometheus Biosciences, Inc. |
| 02/14/2022 |
SC 13G
| Cormorant Asset Management, LP reports a 7.7% stake in GreenLight Biosciences Holdings, PBC |
| 02/14/2022 |
SC 13G
| Cormorant Asset Management, LP reports a 5.6% stake in Tango Therapeutics, Inc. |
| 02/14/2022 |
SC 13G
| Cormorant Asset Management, LP reports a 6.1% stake in Turning Point Therapeutics, Inc. |
| 08/13/2021 |
SC 13G
| Cormorant Asset Management, LP reports a 8.8% stake in Immuneering Corporation |
| 07/12/2021 |
SC 13G
| Cormorant Asset Management, LP reports a 8.3% stake in Aerovate Therapeutics, Inc. |
| 07/09/2021 |
SC 13G
| Cormorant Asset Management, LP reports a 8.7% stake in Elevation Oncology, Inc. |
| 07/08/2021 |
SC 13G
| Cormorant Asset Management, LP reports a 7.2% stake in Monte Rosa Therapeutics, Inc. |
| 07/02/2021 |
SC 13G
| Cormorant Asset Management, LP reports a 6.6% stake in Ambrx Biopharma Inc. |
| 05/19/2021 |
SC 13G
| Cormorant Asset Management, LP reports a 5% stake in Revolution Medicines, Inc. |
| 04/09/2021 |
SC 13G
| Cormorant Asset Management, LP reports a 9.2% stake in Design Therapeutics, Inc. |
| 03/26/2021 |
SC 13G
| Cormorant Asset Management, LP reports a 5.4% stake in Prometheus Biosciences, Inc. |
| 03/26/2021 |
SC 13G
| Cormorant Asset Management, LP reports a 10% stake in Longboard Pharmaceuticals, Inc. |
| 01/19/2021 |
SC 13G
| Cormorant Asset Management, LP reports a 10% stake in Miragen Therapeutics, Inc. |
| 01/04/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/28/2020 |
SC 13G
| Cormorant Asset Management, LP reports a 7.1% stake in BioAtla, Inc. |
| 11/23/2020 |
SC 13G
| Cormorant Asset Management, LP reports a 8.1% stake in Olema Pharmaceuticals, Inc. |
| 11/13/2020 |
SC 13G
| Cormorant Asset Management, LP reports a 8.3% stake in Atea Pharmaceuticals, Inc. |
| 11/12/2020 |
SC 13G
| Cormorant Asset Management, LP reports a 9.3% stake in Galecto, Inc. |
| 10/30/2020 |
SC 13G
| Cormorant Asset Management, LP reports a 9.8% stake in Tarsus Pharmaceuticals, Inc. |
| 10/16/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/20/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/06/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/29/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/29/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|
|
|